share_log
Moomoo 24/7 ·  Apr 22 07:30
Kura Oncology Inc - Registration-Directed Trial of Ziftomenib in Npm1-Mutant Aml on Track to Complete Enrollment by Mid-2024
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment